Filters
Other countries
Results: 1 to 17 of 17
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
SIGMAR1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel PreventionGenetics, part of Exact Sciences United States | 45 | 38 |
|
Amyotrophic Lateral Sclerosis (ALS) Panel PreventionGenetics, part of Exact Sciences United States | 32 | 29 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Hereditary Motor Neuropathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 60 | 26 |
|
Invitae Comprehensive Neuropathies Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 223 | 106 |
|
Distal Hereditary Motor Neuropathy Panel PreventionGenetics, part of Exact Sciences United States | 30 | 22 |
|
Amyotrophic lateral sclerosis 16 (sequence analysis of SIGMAR1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Dementia panel. NGS panel of 21 genes. Genologica Medica Spain | 44 | 21 |
|
Frontotemporal dementia and/or Amyotrophic Lateral Sclerosis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 30 | 30 |
|
Amyotrophic Lateral Sclerosis (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 25 | 30 |
|
AMYOTROPHIC LATERAL SCLEROSIS (ALS) (AUTOSOMAL RECESSIVE) Laboratorio de Genetica Clinica SL Spain | 5 | 5 |
|
Nonprevalent Amyotrophic Lateral Sclerosis Advanced Sequencing Evaluation Athena Diagnostics United States | 24 | 15 |
|
Amyotrophic Lateral Sclerosis Advanced Evaluation Athena Diagnostics United States | 19 | 17 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Amyotrophic Lateral Sclerosis NGS Panel Fulgent Genetics United States | 84 | 43 |
|
Results: 1 to 17 of 17
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.